Withdrawn before start: experimental cocktail for type 1 diabetes never tested
Disease control
Terminated
This pilot study aimed to test whether a combination of four drugs—ATG, low-dose IL-2, adalimumab, and exenatide—could help people newly diagnosed with type 1 diabetes keep producing their own insulin. The trial planned to enroll adults aged 18-35 diagnosed within the last 120 da…
Phase: PHASE1, PHASE2 • Sponsor: Camillo Ricordi and Jay Skyler • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC